Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-50,000
Closed -$12.1M 888
2021
Q1
$12.1M Buy
50,000
+22,000
+79% +$4.9M 0.17% 80
2020
Q4
$5.83M Buy
28,000
+8,000
+40% +$1.57M 0.12% 183
2020
Q3
$3.39M Sell
20,000
-85,000
-81% -$15M 0.09% 141
2020
Q2
$19.7M Buy
105,000
+30,000
+40% +$5.69M 0.44% 49
2020
Q1
$13.3M Buy
+75,000
New +$14.5M 0.27% 83
2019
Q3
Sell
-289,200
Closed -$45.6M 321
2019
Q2
$45.6M Buy
+289,200
New +$45.3M 0.88% 22
2019
Q1
Sell
-460,000
Closed -$87.4M 34
2018
Q4
$87.4M Buy
460,000
+30,000
+7% +$6.26M 3.15% 7
2018
Q3
$89.5M Buy
430,000
+30,000
+8% +$5.56M 2.06% 10
2018
Q2
$68M Buy
+400,000
New +$69.2M 1.36% 12
2015
Q4
Sell
-81,989
Closed -$11.1M 429
2015
Q3
$11.1M Buy
+81,989
New +$11.9M 0.23% 115
2015
Q2
Sell
-3,506
Closed -$454K 771
2015
Q1
$454K Hold
3,506
0.01% 522
2014
Q4
$361K Buy
+3,506
New +$346K 0.01% 505
2013
Q3
Sell
-103,583
Closed -$7.51M 442
2013
Q2
$7.51M Buy
+103,583
New +$6.98M 0.14% 195

Other funds holding CI

UBS O'Connor's CI Position: Q2 2021 in Review

UBS O'Connor sold out of Cigna (CI) in Q2 2021, closing a stake of 50,000 shares — an estimated $12.1M sold.

UBS O'Connor first reported a position in CI in Q2 2013 and held it in 13 quarters. The position peaked at $89.5M in Q3 2018. 1,295 funds tracked by Wall St. Rank hold CI as of Q2 2021.

  • UBS O'Connor reported no remaining Cigna position as of Q2 2021 after selling out during the quarter.
  • UBS O'Connor sold 50,000 Cigna shares in Q2 2021, an estimated $12.1M.
  • UBS O'Connor first reported a position in Cigna in Q2 2013 and held it in 13 quarters.
  • UBS O'Connor's Cigna position peaked at $89.5M in Q3 2018.
  • 1,295 funds tracked by Wall St. Rank held Cigna as of Q2 2021.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.